Intervention

Duloxetine

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 67 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials67

Recruiting0

Common conditions25

Lead sponsors shown15

Clinical trials

60 shown

Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer SurvivorsNCT06711978 · 2024-12-01

Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in KoreaNCT04446039 · 2022-07-04

Neurobiology of Treatment Responses in MDDNCT03068247 · 2021-11-01

Antidepressant Response in Older Adults With Comorbid PTSD and MDDNCT04697693 · 2021-03-03

Botulinum Toxin Type A in Diabetic Peripheral NeuropathyNCT05296759 · 2021-02-01

A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive DisorderNCT04476030 · 2020-11-09

Leveraging EEG for Antidepressant Prediction With Duloxetine and BupropionNCT04388189 · 2020-10-15

A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on DepressionNCT03623711 · 2018-08-01

A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson PatientsNCT02857244 · 2016-11-01

Treatment Outcome in Major Depressive DisorderNCT02869035 · 2016-08-01

Prospective RCT on Post Prostatectomy Urine LeakNCT02367404 · 2015-05-01

Pharmacovigilance in Gerontopsychiatric PatientsNCT02374567 · 2015-01-01

Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks TrialNCT03121573 · 2014-12-15

Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic PainNCT01912612 · 2013-10-30

Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive DisorderNCT01650740 · 2012-08-01

Algorithm Guided Treatment Strategies for Major Depressive DisorderNCT01764867 · 2012-06-01

Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive DisorderNCT01564862 · 2012-04-01

Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)NCT01360866 · 2011-10-01

Inflammatory Markers and Cognitive Function in Major DepressionNCT01391221 · 2011-07-01

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major DepressionNCT01369095 · 2011-07-01

A Study in Participants With Diabetic Peripheral Neuropathic Pain in ChinaNCT01179672 · 2011-04-01

Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major DepressionNCT01309945 · 2011-04-01

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.NCT01288079 · 2011-02-01

Pretreatment Identification of Duloxetine Success in Neuropathic Pain PatientsNCT01363284 · 2010-06-01

Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderNCT01153009 · 2010-06-01

6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive DisorderNCT01145755 · 2010-05-01

Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in AdultsNCT01140906 · 2010-05-01

Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or PregabalinNCT01116531 · 2010-04-01

A Study in Painful Diabetic NeuropathyNCT01089556 · 2010-03-01

A Study in Depression and Associated Painful Physical SymptomsNCT01070329 · 2010-03-01

A Study of the Neurobiology of DepressionNCT01051466 · 2010-01-01

A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful SymptomsNCT01000805 · 2009-11-01

Electroencephalography (EEG) Signal ProcessingNCT01369290 · 2009-10-01

A Study of Patients With Major Depressive Disorder and Residual ApathyNCT00985504 · 2009-09-01

Duloxetine for Major Depression in Peri-/Postmenopausal WomenNCT00889369 · 2009-05-01

Combination Pain Therapy in HIV NeuropathyNCT00863057 · 2009-05-01

Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly PatientsNCT00811252 · 2009-01-01

Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major DepressionNCT01754493 · 2008-12-01

Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated PainNCT01028352 · 2008-10-01

Switching to Duloxetine in Patients With DepressionNCT00696774 · 2008-06-01

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive DisorderNCT00672620 · 2008-04-01

Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive DisorderNCT00635219 · 2008-02-01

Dose-finding Study With Lu AA24530 in Major Depressive DisorderNCT00599911 · 2007-10-01

Study of Brain Response to Emotional Pictures Using a fMRI While on DuloxetineNCT00532480 · 2007-09-01

Safety and Efficacy Study in Subjects With Diabetic Neuropathic PainNCT00507936 · 2007-08-01

Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older AdultsNCT00696293 · 2007-05-01

Pilot Study of Duloxetine in Psychological ResilienceNCT00331799 · 2007-04-01

Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe DepressionNCT02229825 · 2007-02-09

Effects of Pregabalin, Duloxetine & Amitriptyline on Pain & SleepNCT00370656 · 2007-02-01

Duloxetine for Perimenopausal DepressionNCT00517985 · 2007-02-01

A Study to Test the Use of Duloxetine for Pain in MSNCT00457730 · 2007-01-01

Evaluation of the Effects of Duloxetine on NorepinephrineNCT00414323 · 2006-11-01

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderNCT00351910 · 2006-05-01

Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)NCT00322621 · 2006-04-01

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive DisorderNCT00321490 · 2006-04-01

Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort SyndromeNCT01035073 · 2006-04-01

Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive DisorderNCT01148472 · 2005-09-01

Treatment of MDEs During the Course of Psychotic Disorders With DuloxetineNCT00224302 · 2005-08-01

Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and PainNCT02232555 · 2005-05-01

Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive DisorderNCT00105989 · 2005-03-01

Common conditions

Leading sponsors

Eli Lilly and Company 14 H. Lundbeck A/S 5 AstraZeneca 4 New York State Psychiatric Institute 3 Takeda 3 Boehringer Ingelheim 2 Bristol-Myers Squibb 2 University of Michigan Rogel Cancer Center 2 University of Pittsburgh 2 AbbVie (prior sponsor, Abbott) 1 Alexandria University 1 Alto Neuroscience 1 Biogen 1 Brown, Theodore R., M.D., MPH 1 Central Institute of Mental Health, Mannheim 1

Trial status mix

COMPLETED51

TERMINATED6

UNKNOWN6

WITHDRAWN4

Phase mix

PHASE424

PHASE321

PHASE213

NA6

PHASE12

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.